While genetic loss of TP53 occurs in 33% of prostate cancers, a recent report demonstrated that 17% of prostate cancers harbor WT TP53 alleles but exhibit loss of TP53 transcriptional function (8). This evidence concerns the gene TP53 and prostate carcinoma.